Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.59
-0.73 (-7.07%)
At close: May 29, 2026, 4:00 PM EDT
9.55
-0.04 (-0.42%)
After-hours: May 29, 2026, 7:56 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $761.73 million as of May 29, 2026. Its market cap has increased by 229.63% in one year.
Market Cap
761.73M
Enterprise Value
1.13B
1-Year Change
229.63%
Ranking
Category
Stock Price
$9.59
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $761.73M, an increase of 44.51%. That is a compound annual growth rate of 5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 819.72M | -30.54% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 847.88M |
| Odyssey Therapeutics | 845.36M |
| Evommune | 840.31M |
| Theravance Biopharma | 835.67M |
| Aura Biosciences | 827.25M |
| Vor Biopharma | 813.33M |
| CytomX Therapeutics | 807.68M |
| Omeros | 806.99M |